AI Aims to Spot Pancreatic Cancer Years Before Diagnosis

Researchers describe a trio of advances against pancreatic cancer: a drug targeting a key cancer-driving gene, a personalized mRNA vaccine, and an AI imaging tool that can flag cancer years earlier than typical diagnoses. A Mayo Clinic study suggests the AI system could detect pancreatic cancer up to three years before diagnosis, with about 85% overall accuracy and sensitivity higher than radiologists in earlier scans. While promising, experts caution that such tools must be applied to high‑risk populations to avoid false positives and that more work is needed before broad clinical adoption.